Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-18T02:14:54.604Z Has data issue: false hasContentIssue false

Benzodiazepine Addiction and Suicidal Risk in the Elderly

Published online by Cambridge University Press:  31 July 2026

N. Smaoui
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
M. Barkallah*
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
N. Charfi
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
R. Feki
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
M. Maalej
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
I. Gassara
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
S. Omri
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
L. Zouari
Affiliation:
Psychiatry Department “C”, Hedi Chaker Hospital, Sfax, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Prolonged benzodiazepine (BZD) use in elderly individuals has been associated with an increased risk of suicide.

Objectives

This study aimed to investigate the relationship between BZD addiction and suicidal risk in older adults.

Methods

A cross-sectional study was conducted among patients aged 65 years and older attending outpatient psychiatric consultations. Data collected included benzodiazepine use and detailed assessment of suicidal history. Suicidal risk was assessed using the Ducher Suicidal Risk Scale, and benzodiazepine dependence was evaluated with the Benzodiazepine Attachment Scale (ECAB).

Results

Seventy-three patients were included (male/female ratio = 1.08). Among the 51 patients who used benzodiazepines, 41 (80%) met the criteria for dependence. Nearly half of the patients (49%) reported a history of suicide attempts, with an average of 1.86 attempts (range: 1–4) and a mean interval of 24.9 years since the last episode (range: 2–43). Most attempts (58%) were described as impulsive rather than premeditated.

The most frequently reported motives were negative emotions (22%), family conflicts (19%), delusional ideas (17%), and hallucinations (11%). The most common method was intentional drug ingestion (28%), followed by strangulation (17%) and defenestration (17%); anxiolytics were involved in 60% of drug ingestions.

In 86% of cases, the act occurred when the patient was alone, most often at home (67%), predominantly during nighttime hours (20:00–04:00; 44%) and more frequently in autumn (39%). The suicidal act was mainly reactive in nature (44%).

According to the Ducher Suicide Risk Scale, 40% of patients expressed no death-related thoughts, whereas the remaining 60% presented a range from transient thoughts to active suicidal ideation.

BZD-dependent patients had significantly more frequent histories of suicide attempts (p = 0.01), a shorter duration between the last suicide attempt and the current evaluation (p = 0.03), and more frequent suicidal acts motivated by interpersonal conflicts or psychotic symptoms (delusions, hallucinations) (p = 0.045). They also presented suicidal ideation at the time of the interview (p = 0.045) and had higher scores on the Ducher scale compared to non-dependent patients (p = 0.005).

Conclusions

BZD addiction represents an independent risk factor for suicidality in the elderly. Systematic screening for suicidal risk iscommended in patients with chronic BZD use or dependence.

Disclosure of Interest

None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.